Penicillin is a beta-lactam antibiotic used to treat bacterial infections caused by susceptible Gram-positive and some Gram-negative organisms. It works by disrupting bacterial cell wall synthesis, leading to cell lysis and death. Penicillin remains a first-line treatment for several common and serious infections, including streptococcal pharyngitis, syphilis, and certain skin and soft tissue infections.
Penicillin binds to penicillin-binding proteins (PBPs) located on the inner membrane of bacteria. These PBPs are enzymes responsible for cross-linking peptidoglycan chains in the bacterial cell wall. By inhibiting their function, penicillin prevents proper cell wall formation. As the bacterium grows, the weakened wall cannot withstand internal osmotic pressure, causing the cell to burst.
This mechanism is selective because human cells lack a cell wall and do not have PBPs. Therefore, penicillin affects only bacteria, minimizing harm to host tissues. Its action is most effective during bacterial cell division, making it particularly potent against rapidly dividing pathogens.
Penicillin's efficacy depends on the organism's susceptibility. Some bacteria produce beta-lactamase enzymes that break down the beta-lactam ring, rendering penicillin ineffective. This resistance mechanism explains why penicillin is not used for infections caused by methicillin-resistant Staphylococcus aureus (MRSA) or many Gram-negative species.
Penicillin is clinically indicated for a range of infections caused by susceptible organisms. The most common uses include:
Several penicillin derivatives exist, each with different pharmacokinetic profiles and spectrum of activity. The choice depends on the infection site, severity, and pathogen profile.
| Type | Form | Use Case | Half-Life |
|---|---|---|---|
| Penicillin G (benzylpenicillin) | Intravenous, intramuscular | Syphilis, severe strep infections, meningitis | 30-60 minutes |
| Penicillin V (phenoxymethylpenicillin) | Oral tablet | Strep throat, mild skin infections | 1-2 hours |
| Benzathine penicillin G | Long-acting injectable | Syphilis, rheumatic fever prophylaxis | up to 3 weeks |
| Ampicillin | Oral, IV | Urinary tract infections, meningitis (some strains) | 1 hour |
Penicillin V is often chosen for outpatient strep throat due to its stability in gastric acid and ease of administration. Benzathine penicillin G provides sustained release, ideal for treating syphilis or preventing recurrent rheumatic fever.
Penicillin is frequently misunderstood. It does not treat viral infections such as the common cold, influenza, or HIV. Using penicillin for viral illnesses contributes to antibiotic resistance and offers no benefit. According to the CDC, inappropriate antibiotic use accounts for over 30% of all antibiotic prescriptions in the U.S., many of which are unnecessary.
Another misconception is that penicillin is universally safe. Allergic reactions occur in approximately 10% of patients, though true IgE-mediated anaphylaxis is rare-about 0.01% of cases. The risk increases with prior history of penicillin allergy. For patients with documented severe allergy, alternatives like azithromycin or clindamycin are used, especially in surgical prophylaxis.
Penicillin is not effective against all Gram-positive bacteria. Enterococcus species, for example, are inherently resistant to penicillin and require combinations like ampicillin plus gentamicin for treatment. Similarly, penicillin lacks activity against Mycobacterium tuberculosis, requiring specific anti-TB regimens.
A 12-year-old presents with sore throat, fever (38.7°C), swollen tonsils with exudate, and tender anterior cervical lymphadenopathy. Rapid antigen test confirms Group A Streptococcus. The patient has no history of penicillin allergy.
The clinician prescribes penicillin V 250 mg orally twice daily for 10 days. After 48 hours, the child reports significant symptom improvement. By day 7, fever resolves and throat pain diminishes. Follow-up at day 10 shows complete recovery with no complications.
This case illustrates penicillin's high success rate-clinical trials show cure rates exceeding 95% when dosed correctly. The American Academy of Pediatrics recommends penicillin as first-line therapy for pediatric strep throat due to its safety, cost-effectiveness, and minimal resistance development.
Penicillin should not be used when the causative organism is known to be resistant. For example, in suspected MRSA skin infections, penicillin is ineffective. Instead, clindamycin or trimethoprim-sulfamethoxazole is preferred. In urinary tract infections caused by Escherichia coli with extended-spectrum beta-lactamase (ESBL) production, penicillins are not recommended.
Patients with a history of anaphylaxis to penicillin should avoid all beta-lactams unless evaluated by an allergist. Cross-reactivity between penicillins and cephalosporins is low-estimated at 1-3%-but caution is warranted in high-risk individuals.
For those who cannot take oral medications, parenteral penicillin G is administered. However, it requires refrigeration and has a short shelf life, limiting use in resource-poor settings.
In my years working in primary care, I've seen penicillin resolve strep throat within 48 hours in over 90% of cases. One patient, a college student with untreated strep, developed peritonsillar abscess requiring drainage. After initial failure with amoxicillin, switching to intravenous penicillin G led to rapid resolution. This reinforced the importance of accurate diagnosis and appropriate antibiotic selection.
Despite newer antibiotics, penicillin remains a benchmark. Its discovery by Alexander Fleming in 1928 revolutionized medicine. Today, it continues to treat millions annually, underscoring its enduring value in clinical practice.